Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
RGRepligen Corporation logo

Repligen Corporation (RGEN)

NASDAQ Global Select · Currency in USD
$176.93 ▼ -1.78 (-1.00%)
At close: Oct 23, 4:00 PM ET. Market closed.
$176.93 ▲ +0.00 (+0.00%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$178.71
Open
$178.30
Day's Range
$174.90 – $179.25
52 Week Range
$100.99 – $198.87
Volume
1,066,105
Avg. Volume
1,162,375
Market Cap
$11.23B
Beta (5Y Monthly)
1.08
PE Ratio (TTM)
239.09
EPS (TTM)
$0.74
Earnings Date
Oct 27, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$182.00

Profile: Repligen Corporation

Sector
Healthcare
Industry
Medical - Instruments & Supplies
Full-time employees
2,000
CEO
Olivier Loeillot

Repligen Corporation specializes in the creation and distribution of advanced bioprocessing technologies and integrated systems. These solutions are vital for various stages of biological drug production, serving clients across North America, Europe, the Asia Pacific region, and other international markets. The company's diverse product portfolio includes crucial components for biomanufacturing.

Earnings

Next report: Tue, Oct 27, 2026
EPS estimate $0.46 · Revenue est. $206.71M
DateEst.Actual
Jul 28, 2026$0.45$0.54Beat
May 5, 2026$0.38$0.48Beat
Feb 24, 2026$0.44$0.49Beat
Oct 28, 2025$0.42$0.46Beat
Jul 29, 2025$0.40$0.37Miss
Apr 29, 2025$0.35$0.39Beat

Analyst view

Consensus price target
$182.00 ▲ +2.9%
Range $142.00 – $225.00
Rating: Buy
Buy 92% · Hold 8% · Sell 0%

Get free alerts on RGEN and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.